Background: The role of laparoscopy in the treatment of extraperitoneal rectal cancer is still controversial. The aim of the study was to evaluate differences in safety of laparoscopic rectal resection for extraperitoneal cancer, compared with open surgery. Materials and methods: A systematic review from 2000 to July 2012 was performed searching the MEDLINE and EMBASE databases (PROSPERO registration number CRD42012002406). We included randomized and prospective controlled clinical studies comparing laparoscopic and open resection for rectal cancer. Primary endpoints were 30-day mortality and morbidity. Then a meta-analysis was conducted by a fixed-effect model, performing a sensitivity analysis by a random-effect model. Relative risk (RR) was used as an indicator of treatment effect. Results: Eleven studies, representing 1684 patients, met the inclusion criteria: four were randomized for a total of 814 patients. Mortality was observed in 1.2% of patients in the laparoscopic group and in 2.3% of patients in the open group, with an RR of 0.56 (95% CI 0.19-1.64, p ¼ 0.287). The overall incidence of short-term complications was lower in the laparoscopic group (31.5%) compared to the open group (38.2%), with an RR of 0.83 (95% CI 0.73-0.94, p ¼ 0.004). Surgical complications, wound complications, blood loss and the need for blood transfusion, time for bowel movement recovery, food intake recovery, and hospital stay were significantly lower or less frequent in the laparoscopic group. The incidence of intraoperative injuries, anastomotic leakages, and surgical re-interventions was similar in the two groups. Only operative time was in favour of the open group. Conclusions: Based on the evidence of both randomized and prospective controlled series, mortality was lower after laparoscopy although not significantly so, while the short-term morbidity RR, including subgroup analysis, was significantly lower after laparoscopy for extraperitoneal rectal cancer compared to open surgery.
Introduction
Laparoscopy for colon cancer, first described by Jacobs et al. in 1991, 1 aroused interest after the publication of the randomized trial by Lacy et al. in 2002 2 and obtained acceptance after the publication of the three trials COST, COLOR and CLASICC. [3] [4] [5] With the exception of the CLASICC trial, patients with rectal cancer were not included in these studies.
Excellence of surgical technique is of particular relevance in the treatment of rectal cancer. Routine excision of the intact mesorectum during resection of cancers of the middle and lower rectum has resulted in a consistent reduction of local recurrences 6 and in an increase in long-term survival rates. 7 While awaiting long-term oncological results, different studies have reported on postoperative and shortterm results, advocating similar advantages of minimally invasive treatment as for many other procedures, including less pain, shorter postoperative ileus, earlier return to oral intake, shorter hospital stay, and lower blood loss. 8, 9 As the analysis of short-term benefits of laparoscopy should be in some way a prerequisite for the analysis of long-term results, with the present study we intended to evaluate in a meta-analysis whether there are clinically relevant short-term advantages of either laparoscopy or laparotomy for surgical treatment of extraperitoneal rectal cancer in the published literature. While the assessment of laparoscopic advantages in rectal cancer treatment has been the topic of other systematic reviews and meta-analyses in the past, this is the first meta-analysis that specifically focuses on extraperitoneal rectal cancer.
Materials and methods
The methods for the analysis and generation of inclusion criteria were based on the recommendations of the Preferred Reporting Items for Systematic reviews and Meta-Analysis (PRISMA) Statement. 10 According to population, interventions, comparators, outcome measures, and setting (PICOS) criteria, patients were included if affected with extraperitoneal rectal cancer for which laparoscopic or laparotomic treatment was indicated. The study methods were documented Prospero, an international prospective register of systematic reviews (registration number CRD42012 002406).
Studies
Only randomized controlled trials (RCTs) or prospective controlled clinical trials (noRCTs) were considered for this analysis, as suggested by the MOOSE group. 11 Studies were excluded if the study population included colon cancers or intraperitoneal rectal cancers, unless the data were presented separately. When multiple studies from the same institution were identified, the most recent or the most informative was selected. All and only full-text papers in English were considered.
Participants
This meta-analysis compares laparoscopic and laparotomic resection for extraperitoneal rectal cancer with regard to possible benefits of laparoscopy or laparotomy in the short-term postoperative period, defined as up to 30 days after surgery.
Intervention
All surgical procedures involving resection of rectal cancers defined either as of the mid and low rectum, or extraperitoneal or lower than 12 cm from the anal verge, were considered, including partial or total mesorectal excision with mechanical of hand-sutured anastomosis, Hartmann procedures, and abdominoperineal resection. Type of interventions performed were noted in order to analyse separately those involving and those not involving a bowel anastomosis. For the laparoscopic group, any rectal resection performed by means of a mini-invasive approach (i.e. in a space generated by an insufflated pneumoperitoneum with operative field visualization obtained by a videolaparoscope and performed only with laparoscopic trocars) was included, while all procedures described as 'open' or 'conventional' and performed by means of an abdominal laparotomic incision were considered as open surgery.
Outcome measures
Primary endpoints were overall mortality and morbidity at 30 days after surgery. Intraoperative and early (<30 days) postoperative complications directly related to surgery, and early (<30 days) postoperative medical complications were the subject of different sensitivity analyses. Anastomotic leakage, bleeding and blood loss, wound infection and/or wound dehiscence, pelvic and/or abdominal abscesses, and bowel and/or vascular and/or urological injuries were classified as surgical complications. Paralitic ileum and/or non-surgical bowel obstruction, respiratory events, cardiovascular events, deep venous thrombosis and/or pulmonary embolism, urinary infection, urinary retention, nonsurgical infections, or sepsis were classified as medical complications.
The secondary outcome measures were incidence of anastomotic leakage, abscesses, blood loss, time to first bowel movement, time for intake recovery, need for transfusion, length of hospital stay, wound infections, internal organ injuries, need for re-intervention, and operative time.
Results

Study selection
The search retrieved 5017 studies. Figure 1 illustrates the PRISMA flowchart for study inclusion and exclusion criteria.
Characteristics of included studies
The characteristics of the 11 studies meeting the inclusion criteria are summarized in Table 1 . [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] All 11 studies were reported as full papers and included a total of 1684 patients. Four studies were RCTs for a total of 814 patients and seven studies were noRCTs for a total of 870 patients. Table 3 shows characteristics of tumour location and stage, adjuvant therapy, and percentage of protective ileostomy.
Risk of bias of included studies
Assessment of quality according to the Cochrane Collaboration's tool for assessing risk of bias for RCTs and to the Newcastle-Ottawa Scale for prospective noRCTs are represented in Tables 4 and 5, respectively. Figure 2 shows the potential sources of heterogeneity within all studies by a L'Abbe´plot on mortality outcome. Since in most of the analyses I 2 was <50%, the fixed-effects and random-effects model results can be considered comparable.
Quality analysis
Primary outcomes
The meta-analyses of the two primary outcomes investigated mortality and overall complications. For the first primary outcome, the raw incidence of mortality, as reported in five studies, was lower in the laparoscopic group (1.2%) compared to the open group (2.3%). The overall relative risk (RR) was 0.56 (95% CI 0.19-1.64, p ¼ 0.287), showing no heterogeneity (I 2 ¼ 0%) and no differences between RCTs vs. noRCTs subgroups (RR 0.75 vs. 0.41, p ¼ 0.590; Figure 3 ). Performing a cumulative meta-analysis with these five studies (two RCTs and three noRCTs), adding one study at a time by publication date, the RR progressively raised from 0.33 to 0.59; performing an influential meta-analysis, by omitting one study in turn, the RR ranged from 0.50 to 0.60 over the whole time frame.
For the second primary outcome, the incidence of overall 30-day morbidity, as reported in 10 studies, was significantly lower in the laparoscopic (31.5%) compared to the open group (38.2%). The overall RR was 0.83 (95% CI 0.73-0.94, p ¼ 0.004), showing very low heterogeneity (I 2 ¼ 8.2%) and no statistically significant differences between RCT vs. noRCT trials (RR 0.84 vs. 0.83, p ¼ 0.934; Figure 4 ). Performing a cumulative meta-analysis with these 10 studies (four RCTs and six noRCTs), the RR varied from 0.96 to 0.70, being almost constant in the period 2007-2011. In the influential meta-analysis, the RR resulted almost stable over the whole publication period, ranging between 0.81 and 0.86.
Secondary outcomes
As secondary outcomes, the meta-analysis investigated medical and surgical complications in detail, i.e. patients with medical and/or surgical complications, surgical duration, mean blood loss, incidence of intraoperative injuries, bowel movement recovery, food intake recovery, blood transfusions, incidence of abscesses, incidence of wound complications, incidence of anastomotic leakages, incidence of re-intervention, and length of hospital stay. Surgical complications, as reported in 10 studies, were significantly less frequent in the laparoscopic vs. the open group (13.5 vs. 17.5%); the overall RR was 0.78 (95% CI 0.62-0.97, p ¼ 0.027; Figure 5 ), with no differences between RCT vs. noRCT subgroups (RR 0.65 vs. 0.86, p ¼ 0.247).
Patients with medical complications, as reported in nine studies, were 18.5% in the laparoscopic group and 22.0% in the open surgery arm; the overall RR was 0.85 (95% CI 0.70-1.04, p ¼ 0.114; Figure 6 ), again with no differences between RCTs and noRCTs (RR 0.95 vs. 0.73, p ¼ 0.201). 15 Yes All but one study 12 provided conversion to open surgery rate. Overall, 61 laparoscopic cases out of 740 were converted to laparotomy (8.2%): 4.7% (15/322) in the RCT studies and 11.0% (46/418) in the noRCT studies.
Conversion rates ranged between 1.2% 15 and 9.8% 17 in the RCT studies, and between 0% 20 and 18.4% 13 in the noRCT studies. In the RCT studies, reported conversion rates showed a time trend, which was not apparent in the noRCTs (Table 1) .
The weighted mean operative time, as reported in 10 studies, was significantly longer for laparoscopic surgery (216 and 179 minutes, respectively); the overall mean difference (MD) was 36.4 minutes (95% CI 25.1-47.6, p < 0.001; Figure 7) , with no notable MDs between RCTs and noRCTs (32.4 vs. 39.4 minutes, p ¼ 0.557), but with considerable heterogeneity (I 2 83.4%).
The weighted mean blood loss, as reported in eight studies, was almost halved in the laparoscopic group (226 vs. 412 ml); the overall MD was À138 ml (95% CI À195 to À81, p < 0.001; Figure 8 ), with borderline subgroup differences (MD À83 vs. À181, p ¼ 0.056) and consistent heterogeneity (I 2 83.4%).
The overall incidence of intra-operative injuries, as reported in six studies, was 1.4% in both laparoscopic and open surgery patients; the overall RR was 1.10 (95% CI 0.41-2.91, p ¼ 0.851; Figure 9 ), with no differences between RCTs and noRCTs (RR 1.65 vs. 0.74
The weighted mean time for bowel movement recovery, as reported in six studies, was significantly shorter in the laparoscopic group (3.5 vs. 4.7 days); the overall MD was À1.3 days (95% CI À1.8 to À0.9, p < 0.001; Figure 10 ), with no significant MD between RCTs and noRCTs (MD À1.2 vs. À1.3, p ¼ 0.827) but in the presence of extreme heterogeneity (I 2 83.9%). The weighted mean food intake recovery, as reported in nine studies, occurred after 4.0 days in the laparoscopic group and 4.8 days in the open surgery group, significantly favouring the former; the overall MD was À0.9 days (95% CI À1.4 to À0.4, p < 0.001; Figure 11 ), showing a significant MD between RCTs and noRCTs (MD À0.3 vs. À1.0, p ¼ 0.031) and extreme heterogeneity (I 2 75.9%). The percentage of laparoscopic patients requiring blood transfusions, as reported in three studies, was significantly lower than that for open surgery patients (4.5 vs. 7.0%); the overall RR was 0.55 (95% CI 0.31-0.98, p ¼ 0.041; Figure 12 ), in the absence of subgroup differences (RR 0.33 vs. 0.57, p ¼ 0.749).
Abscesses, as reported in seven studies, were observed in 1.8% of patients in the laparoscopic group and 1.9% of patients in the open group; the overall RR was 1.08 (95% CI 0.50-2.36, p ¼ 0.837; Figure 13 ), showing no subgroup differences (RR 1.00 vs. 1.14, p ¼ 0.871).
On the other hand, wound complications, as reported in 10 studies, were described for 6.9% laparoscopic and 11.1% open patients; the overall RR was 0.63 (95% CI 0.46-0.86, p ¼ 0.004; Figure 14 ), with no subgroup differences (RR 0.57 vs. 0.66, p ¼ 0.646).
Anastomotic leakages, as reported in eight studies, occurred in 6.9% of laparoscopic patients and 6.3% of open patients. The overall RR was 1.05 (95% CI 0.68-1.61, p ¼ 0.833; Figure 15 ), with no differences between RCTs and noRCTs (RR 0.66 vs. 1.26,
Patients who needed surgical re-intervention within the first 30 postoperative days, as reported in six studies, were 5.3% in the laparoscopic group and 6.9% in the open group; the overall RR was 0.75 (95% CI 0.47-1.19, p ¼ 0.217; Figure 16 ), again with no subgroup differences (RR 0.71 vs. 0.78, p ¼ 0.838).
The weighted mean duration for hospital stay, as reported in 10 studies, was clearly shorter in the Figure 11 . Forest plot for food intake recovery. CI, confidence interval; MD, mean difference; W, weight of single study. laparoscopy surgery patients (10.2 vs. 12.4 days); the overall MD was À2.2 days (95% CI À3.7 to À0.7, p ¼ 0.005; Figure 17 ), with no differences in the subgroup analysis (MD À2.7 vs. À1.9, p ¼ 0.651), but with extreme heterogeneity (I 2 79.8%).
Discussion
According to European registries, the prevalence of rectal cancer exceeds 50 cases per 100,000 (women and men Figure 16 . Forest plot for incidence of re-intervention. CI, confidence interval; RR, relative risk; W, weight of single study. cancer cases 23, 24 representing one of the leading causes of cancer mortality, in which local recurrence of rectal cancer plays a major role. For mid and low rectal cancers, total mesorectal excision remains the main-stay of therapy. The feasibility of laparoscopic resection of rectal cancer has been demonstrated for many years when performed by expert laparoscopists, but while the laparoscopic approach in colon cancer has been proved to be safe and feasible with equivalent longterm oncological outcome compared to open surgery, 3-5 the safety of laparoscopic surgery for rectal cancer is still debated both for short-term and longterm outcomes.
While mid and long-term oncological results are awaited, the present study aimed to assess by means of a systematic review and meta-analysis, the shortterm safety of laparoscopic resection for extraperitoneal rectal cancer. Different meta-analyses have compared laparoscopic and open techniques for colorectal [25] [26] [27] [28] [29] and later for rectal cancers, [30] [31] [32] [33] although only including intra-peritoneal lesions. This is in fact the first meta-analysis that focuses only on extra-peritoneal rectal cancers. In this restricted field of mid and low rectal surgery, the issue of increased technical challenges arises.
Since 2000, 11 studies [12] [13] [14] [15] [16] [17] [18] [19] [20] [21] [22] have been published comparing laparoscopic and open rectal resection in terms of safety. We restricted the beginning of the analysis to the year 2000 in order to include studies performed with a relative experience of the technique, as it had already been proposed around 8 years previously. This was considered important in order to obtain results as homogeneous as possible. Although a meta-analysis of only RCT studies might be considered preferable, the risk of bias analysis and the heterogeneity test showed that extending the inclusion criteria to prospective non-randomized matched series would have allowed a consistent level of evidence to be maintained. The heterogeneity of results was null or kept within a reasonable range for most of the outcomes considered, in particular for the two primary ones, despite the fact that some of the study samples included in this analysis were relatively small and that none of the studies included had made an estimate of what sample size was needed to detect any differences between laparoscopic and open surgery based on a well-defined primary outcome. The sensitivity analyses showed that no study played an influential role on RR in the whole time period. Where data were available, stage of cancer disease, neoadjuvant chemoradiotherapy, protective ileostomy rates, and type of surgery (partial or total mesorectal excision or abdominoperineal resection) were all variables considered in the comparative analysis between open and laparoscopic groups. The quality assessment for both RCT and noRCT studies as measured by the Cochrane Collaboration's tool for assessing risk of bias and the Newcastle-Ottawa scale was interestingly high. 
